Healthcare Realty Trust (NYSE:HR) Downgraded by JPMorgan Chase & Co. to “Neutral”

JPMorgan Chase & Co. downgraded shares of Healthcare Realty Trust (NYSE:HR) from an overweight rating to a neutral rating in a research report sent to investors on Friday morning, Marketbeat.com reports. JPMorgan Chase & Co. currently has $19.00 price objective on the real estate investment trust’s stock.

Separately, Wells Fargo & Company reiterated an “underweight” rating and set a $17.00 price objective (up previously from $16.00) on shares of Healthcare Realty Trust in a research report on Tuesday, October 1st. One equities research analyst has rated the stock with a sell rating and five have given a hold rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus price target of $17.50.

Healthcare Realty Trust Stock Up 1.1 %

Shares of Healthcare Realty Trust stock opened at $16.88 on Friday. Healthcare Realty Trust has a 52 week low of $12.77 and a 52 week high of $18.90. The firm has a market capitalization of $5.98 billion, a P/E ratio of -10.68 and a beta of 0.93. The company has a 50 day moving average price of $17.72 and a 200 day moving average price of $17.52.

Healthcare Realty Trust Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, November 27th. Stockholders of record on Tuesday, November 12th were given a dividend of $0.31 per share. The ex-dividend date was Tuesday, November 12th. This represents a $1.24 annualized dividend and a dividend yield of 7.35%. Healthcare Realty Trust’s dividend payout ratio is presently -78.48%.

Insider Buying and Selling at Healthcare Realty Trust

In other Healthcare Realty Trust news, COO Robert E. Hull sold 10,000 shares of Healthcare Realty Trust stock in a transaction that occurred on Tuesday, December 17th. The stock was sold at an average price of $17.48, for a total value of $174,800.00. Following the transaction, the chief operating officer now directly owns 171,400 shares of the company’s stock, valued at $2,996,072. The trade was a 5.51 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, Director Thomas N. Bohjalian bought 7,750 shares of the firm’s stock in a transaction that occurred on Friday, November 22nd. The shares were purchased at an average cost of $17.39 per share, for a total transaction of $134,772.50. Following the completion of the transaction, the director now owns 50,002 shares of the company’s stock, valued at $869,534.78. This represents a 18.34 % increase in their ownership of the stock. The disclosure for this purchase can be found here. In the last ninety days, insiders bought 18,750 shares of company stock valued at $323,723. 0.56% of the stock is owned by corporate insiders.

Institutional Trading of Healthcare Realty Trust

Institutional investors and hedge funds have recently made changes to their positions in the business. Franklin Resources Inc. raised its stake in Healthcare Realty Trust by 3.6% in the third quarter. Franklin Resources Inc. now owns 180,958 shares of the real estate investment trust’s stock valued at $3,160,000 after buying an additional 6,238 shares during the period. Wilmington Savings Fund Society FSB acquired a new stake in shares of Healthcare Realty Trust in the third quarter valued at about $78,000. Sanctuary Advisors LLC acquired a new position in shares of Healthcare Realty Trust in the 3rd quarter valued at about $194,000. Barclays PLC raised its position in shares of Healthcare Realty Trust by 116.2% during the third quarter. Barclays PLC now owns 722,582 shares of the real estate investment trust’s stock worth $13,117,000 after purchasing an additional 388,305 shares during the period. Finally, Y Intercept Hong Kong Ltd bought a new stake in Healthcare Realty Trust during the 3rd quarter worth approximately $849,000.

Healthcare Realty Trust Company Profile

Healthcare Realty (NYSE: HR) is a real estate investment trust (REIT) that owns and operates medical outpatient buildings primarily located around market-leading hospital campuses. The Company selectively grows its portfolio through property acquisition and development. As the first and largest REIT to specialize in medical outpatient buildings, Healthcare Realty's portfolio includes more than 700 properties totaling over 40 million square feet concentrated in 15 growth markets.